Research Abstract
Human Study
After 12 years from the start of the trial, the patients in the Viscum arm continue to show a considerably longer PRDFS compared to oral etoposide.
Long-Term Follow-up of a Randomized Study of Oral Etoposide versusFermentatum Pini as Maintenance Therapy in Osteosarcoma Patients in Complete Surgical Remission after Second Relapse.
AI Summary
Key Findings
0:00 / 0:00
0:00 / 0:00
Abstract
Background: In relapsed osteosarcoma, the 5-yr postrelapse disease-free survival (PRDFS) rate after the second relapse is
Affiliation
Alessandra Longhi
External References
- PubMed ID:
- 32398946
Related Topics
Chemotherapeutic
(1,732)
Mistletoe
(896)
Osteosarcoma
(666)
Superiority of Natural Substances versus Drugs
(411)
Substance
Health Topic
Action
Keyword
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.